Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Daiichi Sankyo
Medtronic
Cerilliant
Cantor Fitzgerald
UBS
Farmers Insurance
AstraZeneca
Argus Health

Generated: May 24, 2018

DrugPatentWatch Database Preview

VOGELXO Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Vogelxo, and what generic alternatives are available?

Vogelxo is a drug marketed by Upsher-smith Labs and is included in one NDA. There are three patents protecting this drug.

This drug has eight patent family members in eight countries.

The generic ingredient in VOGELXO is testosterone. There are sixty-three drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the testosterone profile page.
Summary for VOGELXO
International Patents:8
US Patents:3
Applicants:1
NDAs:1
Suppliers / Packagers: 2
Bulk Api Vendors: 53
Formulation / Manufacturing:see details
DailyMed Link:VOGELXO at DailyMed
Drug patent expirations by year for VOGELXO
Pharmacology for VOGELXO
Ingredient-typeAndrostanes
Drug ClassAndrogen
Mechanism of ActionAndrogen Receptor Agonists
Medical Subject Heading (MeSH) Categories for VOGELXO

US Patents and Regulatory Information for VOGELXO

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Upsher-smith Labs VOGELXO testosterone GEL, METERED;TRANSDERMAL 204399-003 Jun 4, 2014 BX RX No No ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Upsher-smith Labs VOGELXO testosterone GEL;TRANSDERMAL 204399-002 Jun 4, 2014 AB2 RX No No ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Upsher-smith Labs VOGELXO testosterone GEL, METERED;TRANSDERMAL 204399-003 Jun 4, 2014 BX RX No No ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Upsher-smith Labs VOGELXO testosterone GEL, METERED;TRANSDERMAL 204399-003 Jun 4, 2014 BX RX No No ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Queensland Health
Moodys
Covington
Cerilliant
Cantor Fitzgerald
US Army
Fuji
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.